VisVires New Protein

Summary

In 2014 was created VisVires New Protein, which is appeared as VC. The main department of described VC is located in the Singapore. The venture was found in Asia in Singapore.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the VisVires New Protein, startups are often financed by Emertec Gestion, Demeter Partners, Wilco. The meaningful sponsors for the fund in investment in the same round are Emertec Gestion, Bpifrance, Talis Capital. In the next rounds fund is usually obtained by Bpifrance, Talis Capital, Idinvest Partners.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 2 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Ireland. Among the various public portfolio startups of the fund, we may underline Ynsect, Nuritas, mittemitte We can highlight the next thriving fund investment areas, such as Health Care, Therapeutics.

The fund was created by Matthieu Vermersch.

Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.